About BioImage
BioImage is a company based in Copenhagen (Denmark) founded in 1999 was acquired by Thermo Fisher Scientific in April 2006.. BioImage has raised $30.47 million across 2 funding rounds from investors including Thermo Fisher Scientific, Novo Nordisk and Apax Partners. BioImage operates in a competitive market with competitors including Lodestone Biomedical, BioAmp Diagnostics, ACS Biomarker, HAWK Biosystems and Araceli Biosciences, among others.
- Headquarter Copenhagen, Denmark
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30.47 M (USD)
in 2 rounds
-
Latest Funding Round
$13.47 M (USD), Series B
Jan 23, 2002
-
Investors
Thermo Fisher Scientific
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Thermo Fisher Scientific
(Apr 26, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioImage
BioImage has successfully raised a total of $30.47M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13.47 million completed in January 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $13.5M
-
First Round
First Round
(28 Apr 1999)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2002 | Amount | Series B - BioImage | Valuation |
investors |
|
| Apr, 1999 | Amount | Series A - BioImage | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioImage
BioImage has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Novo Nordisk and Apax Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity investments are focused on tech, services, and consumer sectors.
|
Founded Year | Domain | Location | |
|
Early stage venture capital firm investing in US
|
Founded Year | Domain | Location | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioImage
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioImage
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioimage Comparisons
Competitors of BioImage
BioImage operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lodestone Biomedical, BioAmp Diagnostics, ACS Biomarker, HAWK Biosystems and Araceli Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
|
|
| domain | founded_year | HQ Location |
Developers of diagnostic tests that help to treat patient with a specific antibiotic
|
|
| domain | founded_year | HQ Location |
Novel biomarkers for cardiac disease are discovered, validated, and commercialized.
|
|
| domain | founded_year | HQ Location |
Clinical assays are developed for quantifying novel biomarkers in samples.
|
|
| domain | founded_year | HQ Location |
Scientific tools for tissue and cell-based biomarker discovery are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BioImage
When was BioImage founded?
BioImage was founded in 1999.
Where is BioImage located?
BioImage is headquartered in Copenhagen, Denmark.
Is BioImage a funded company?
BioImage is a funded company, having raised a total of $30.47M across 2 funding rounds to date. The company's 1st funding round was a Series A of $17M, raised on Apr 28, 1999.
What does BioImage do?
BioImage was founded in 1999 in Copenhagen, Denmark, within the biotechnology sector. Proprietary bioassays are developed and sold to biopharmaceutical companies and research institutions, with contract-based development services also provided. Broad patents cover Enhanced GFP, GFP-based biosensors, and protein fusions to luminophores, enabling translocation monitoring in cells for drug discovery. This intellectual property supports collaborations and out-licensing with industry partners.
Who are the top competitors of BioImage?
BioImage's top competitors include Araceli Biosciences, Lodestone Biomedical and BioAmp Diagnostics.
Who are BioImage's investors?
BioImage has 5 investors. Key investors include Thermo Fisher Scientific, Novo Nordisk, Apax Partners, Abingworth, and Novo Holdings.